| Financial Year |
March 31 2023 |
| Monetary Funds |
104,410,425.86 |
| Held-for-trading Financial Assets |
652,753,711.81 |
| Notes Receivable |
2,682,312.80 |
| Accounts Receivable |
143,904,502.52 |
| Advances to Suppliers |
4,151,264.81 |
| Other Receivables |
5,960,424.16 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
176,580,840.01 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,655,206.01 |
| Total Current Assets |
1,092,303,980.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
1,926,605.80 |
| Fixed Assetes |
184,160,662.28 |
| Under-construction Projects |
119,117,335.72 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,618,087.62 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
10,213,961.15 |
| Other Non-Current Assets |
5,182,524.95 |
| Sub-Total of Non-Current Assets |
371,314,035.00 |
| Total Assets |
1,463,618,015.87 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
8,822,267.50 |
| Accounts Payable |
169,042,264.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,895,752.66 |
| Taxes Payable |
4,549,975.58 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,959,712.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
65,570.64 |
| Other Current Liabilities |
2,821,829.73 |
| Sub-Total of Current Liabilities |
212,811,292.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,862,977.15 |
| Other Non-Current Liabilities |
15,521,886.81 |
| Sub-Total of Non-Current Liabilities |
50,346,154.14 |
| Total Liabilities |
263,157,446.95 |
| Paid-In Capital(Or Share Stock) |
133,340,000.00 |
| Capital Surplus |
694,606,835.30 |
| Surplus Reserve |
60,255,069.61 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
312,144,552.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,200,460,568.92 |
| Owner's Equity（Stockholder's Equity） |
1,200,460,568.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,463,618,015.87 |
